- Home
- LVO vs CLNN Comparison
LVO vs CLNN Comparison
Compare LVO & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- CLNN
- Stock Information
- Founded
- LVO 2009
- CLNN 2012
- Country
- LVO United States
- CLNN United States
- Employees
- LVO N/A
- CLNN N/A
- Industry
- LVO Restaurants
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- LVO Consumer Discretionary
- CLNN Health Care
- Exchange
- LVO Nasdaq
- CLNN Nasdaq
- Market Cap
- LVO 68.1M
- CLNN 60.3M
- IPO Year
- LVO N/A
- CLNN N/A
- Fundamental
- Price
- LVO $4.30
- CLNN $9.42
- Analyst Decision
- LVO Strong Buy
- CLNN Strong Buy
- Analyst Count
- LVO 2
- CLNN 6
- Target Price
- LVO $14.00
- CLNN $32.67
- AVG Volume (30 Days)
- LVO 109.7K
- CLNN 149.6K
- Earning Date
- LVO 11-06-2025
- CLNN 11-12-2025
- Dividend Yield
- LVO N/A
- CLNN N/A
- EPS Growth
- LVO N/A
- CLNN N/A
- EPS
- LVO N/A
- CLNN N/A
- Revenue
- LVO $100,534,000.00
- CLNN $286,000.00
- Revenue This Year
- LVO N/A
- CLNN N/A
- Revenue Next Year
- LVO $25.61
- CLNN $1,363.77
- P/E Ratio
- LVO N/A
- CLNN N/A
- Revenue Growth
- LVO N/A
- CLNN N/A
- 52 Week Low
- LVO $4.01
- CLNN $2.28
- 52 Week High
- LVO $16.00
- CLNN $11.06
- Technical
- Relative Strength Index (RSI)
- LVO N/A
- CLNN 66.11
- Support Level
- LVO N/A
- CLNN $8.54
- Resistance Level
- LVO N/A
- CLNN $11.00
- Average True Range (ATR)
- LVO 0.00
- CLNN 0.83
- MACD
- LVO 0.00
- CLNN 0.29
- Stochastic Oscillator
- LVO 0.00
- CLNN 62.27
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.